Alimera Sciences

About:

Alimera Sciences is a biopharmaceutical company that focuses on retinal health.

Website: http://www.alimerasciences.com

Top Investors: Hercules Capital, Deerfield, Sofinnova Investments, New Enterprise Associates, Polaris Partners

Description:

Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is passionate about protecting the retina and developing innovative treatments to preserve vision.

Total Funding Amount:

$304M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Alpharetta, Georgia, United States

Founded Date:

2003-01-01

Contact Email:

customerservice(AT)alimerasciences.com

Founders:

Dan Myers, Dave Holland

Number of Employees:

51-100

Last Funding Date:

2021-04-14

IPO Status:

Public

Industries:

Biotechnology

Health Care

Medical